Katz SD - Search Results

1

Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure.

Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, Yasskiy A. Katz SD, et al. Circulation. 2005 Jan 25;111(3):310-4. doi: 10.1161/01.CIR.0000153349.77489.CF. Epub 2005 Jan 17. Circulation. 2005. PMID: 15655134

2

Control of arteriolar resistance in heart failure. Partial attenuation of specific phosphodiesterase inhibitor-mediated vasodilation by digitalis glycosides.

Jondeau G, Klapholz M, Katz SD, Maher M, Galvao M, Levato P, LeJemtel TH. Jondeau G, et al. Among authors: katz sd. Circulation. 1992 Jan;85(1):54-60. doi: 10.1161/01.cir.85.1.54. Circulation. 1992. PMID: 1728484

3

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD, et al. Krum H, et al. Among authors: katz sd. Circulation. 1995 Sep 15;92(6):1499-506. doi: 10.1161/01.cir.92.6.1499. Circulation. 1995. PMID: 7664433 Clinical Trial.

4

Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation.

Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijou R, LeJemtel TH. Katz SD, et al. Circulation. 1994 Jul;90(1):12-6. doi: 10.1161/01.cir.90.1.12. Circulation. 1994. PMID: 8025986

5

Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure.

Schwarz M, Katz SD, Demopoulos L, Hirsch H, Yuen JL, Jondeau G, LeJemtel TH. Schwarz M, et al. Among authors: katz sd. Circulation. 1994 Apr;89(4):1609-14. doi: 10.1161/01.cir.89.4.1609. Circulation. 1994. PMID: 8149528

6

Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.

Katz SD, Schwarz M, Yuen J, LeJemtel TH. Katz SD, et al. Circulation. 1993 Jul;88(1):55-61. doi: 10.1161/01.cir.88.1.55. Circulation. 1993. PMID: 8391403

7

Coupling of hemodynamic measurements with oxygen consumption during exercise does not improve risk stratification in patients with heart failure.

Mancini D, Katz S, Donchez L, Aaronson K. Mancini D, et al. Circulation. 1996 Nov 15;94(10):2492-6. doi: 10.1161/01.cir.94.10.2492. Circulation. 1996. PMID: 8921793

8

Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure.

Katz SD, Khan T, Zeballos GA, Mathew L, Potharlanka P, Knecht M, Whelan J. Katz SD, et al. Circulation. 1999 Apr 27;99(16):2113-7. doi: 10.1161/01.cir.99.16.2113. Circulation. 1999. PMID: 10217650

9

Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure.

Katz SD, Balidemaj K, Homma S, Wu H, Wang J, Maybaum S. Katz SD, et al. J Am Coll Cardiol. 2000 Sep;36(3):845-51. doi: 10.1016/s0735-1097(00)00790-7. J Am Coll Cardiol. 2000. PMID: 10987609 Free article. Clinical Trial.

10

Effects of beta-blockers on neurohormonal activation in patients with congestive heart failure.

Baran D, Horn EM, Hryniewicz K, Katz SD. Baran D, et al. Among authors: katz sd. Drugs. 2000 Nov;60(5):997-1016. doi: 10.2165/00003495-200060050-00003. Drugs. 2000. PMID: 11129131 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters